Product Introduction:
Lenmid 10mg is a prescription medication used to treat various hematological cancers. It is most commonly used in combination with other therapies or as a monotherapy for specific cancer types. Manufactured with strict quality standards, Lenmid is widely used in oncology across the globe.
Uses:
Lenmid 10mg is used for the treatment of:
-
Multiple Myeloma – in combination with dexamethasone or other agents.
-
Myelodysplastic Syndromes (MDS) – particularly those with chromosome 5q deletion.
-
Mantle Cell Lymphoma (MCL) – in patients who have relapsed or become resistant to other treatments.
-
Follicular Lymphoma – when used as a second-line or later treatment.
-
Chronic Lymphocytic Leukemia (CLL) – under clinical guidance.
-
Cutaneous T-cell Lymphoma (CTCL) – in selected cases where other treatments fail.
Storage Instructions:
-
Store below 25°C.
-
Keep in original packaging to protect from moisture.
-
Keep out of reach of children.
-
Do not use after the expiry date printed on the packaging.
How It Works (Mechanism of Action):
Lenalidomide works by modifying the immune system and inhibiting the growth of cancerous cells. It enhances T-cell and natural killer (NK) cell-mediated immunity, promotes apoptosis (programmed cell death) of cancer cells, and inhibits angiogenesis (formation of new blood vessels that supply tumors).
Side Effects:
Common side effects:
-
Fatigue
-
Diarrhea or constipation
-
Rash
-
Nausea
-
Dizziness
-
Low blood cell counts (anemia, neutropenia, thrombocytopenia)
Severe side effects:
-
Blood clots (deep vein thrombosis, pulmonary embolism)
-
Liver toxicity
-
Severe skin reactions
-
Tumor lysis syndrome
-
Secondary cancers in rare cases
Seek immediate medical help if serious side effects occur.
Dosage (Typical Recommended Dose):
-
The usual starting dose is 10 mg once daily, depending on the condition being treated.
-
Dose may be adjusted based on patient response, kidney function, and tolerance.
-
Treatment cycles may include 21 days on drug followed by 7 days off.
Method of Administration:
-
Take the capsule orally with water.
-
Swallow whole, do not crush or chew.
-
Can be taken with or without food.
-
Follow the dosing schedule as prescribed by your oncologist.
Precautions:
-
Not recommended during pregnancy; causes severe birth defects.
-
Use effective contraception (both males and females) during and for several weeks after treatment.
-
Regular blood tests are essential to monitor blood counts.
-
Avoid if you have a history of blood clots unless prescribed with precautions.
-
Inform your doctor if you have liver, kidney, or heart problems.
Drug Interactions:
Lenmid may interact with:
-
Dexamethasone (increases risk of blood clots)
-
Erythropoietin-stimulating agents
-
Anticoagulants (warfarin, enoxaparin)
-
Immunosuppressants
-
Other chemotherapy drugs
-
Hormonal therapies
Always inform your doctor of all medications and supplements you're taking.
Aller gies:
-
Do not use if allergic to Lenalidomide or any of its excipients.
-
Symptoms of allergic reactions may include rash, itching, swelling, dizziness, or difficulty breathing.
Overdose Information:
-
In case of an overdose, seek emergency medical help immediately.
-
Symptoms may include severe dizziness, fainting, or extreme fatigue.
-
There is no specific antidote; treatment is supportive and symptom-based.
Missed Dose Instructions:
-
If you miss a dose and it’s less than 12 hours late, take it as soon as remembered.
-
If more than 12 hours late, skip the missed dose and resume your regular schedule.
-
Do not double the dose to make up for a missed one.
Additional Notes:
-
This medication is part of a Risk Evaluation and Mitigation Strategy (REMS) program in some countries due to its teratogenic effects.
-
Handle capsules with care; avoid opening or crushing them.
-
Periodic monitoring for blood counts and organ function is necessary.
-
Patients should carry identification stating they are on Lenalidomide therapy.
-
Avoid activities requiring alertness (e.g., driving) until you know how the drug affects you.
Product Introduction:
Lenmid 10mg is a prescription medication used to treat various hematological cancers. It is most commonly used in combination with other therapies or as a monotherapy for specific cancer types. Manufactured with strict quality standards, Lenmid is widely used in oncology across the globe.
Uses:
Lenmid 10mg is used for the treatment of:
-
Multiple Myeloma – in combination with dexamethasone or other agents.
-
Myelodysplastic Syndromes (MDS) – particularly those with chromosome 5q deletion.
-
Mantle Cell Lymphoma (MCL) – in patients who have relapsed or become resistant to other treatments.
-
Follicular Lymphoma – when used as a second-line or later treatment.
-
Chronic Lymphocytic Leukemia (CLL) – under clinical guidance.
-
Cutaneous T-cell Lymphoma (CTCL) – in selected cases where other treatments fail.
Storage Instructions:
-
Store below 25°C.
-
Keep in original packaging to protect from moisture.
-
Keep out of reach of children.
-
Do not use after the expiry date printed on the packaging.
How It Works (Mechanism of Action):
Lenalidomide works by modifying the immune system and inhibiting the growth of cancerous cells. It enhances T-cell and natural killer (NK) cell-mediated immunity, promotes apoptosis (programmed cell death) of cancer cells, and inhibits angiogenesis (formation of new blood vessels that supply tumors).
Side Effects:
Common side effects:
-
Fatigue
-
Diarrhea or constipation
-
Rash
-
Nausea
-
Dizziness
-
Low blood cell counts (anemia, neutropenia, thrombocytopenia)
Severe side effects:
-
Blood clots (deep vein thrombosis, pulmonary embolism)
-
Liver toxicity
-
Severe skin reactions
-
Tumor lysis syndrome
-
Secondary cancers in rare cases
Seek immediate medical help if serious side effects occur.
Dosage (Typical Recommended Dose):
-
The usual starting dose is 10 mg once daily, depending on the condition being treated.
-
Dose may be adjusted based on patient response, kidney function, and tolerance.
-
Treatment cycles may include 21 days on drug followed by 7 days off.
Method of Administration:
-
Take the capsule orally with water.
-
Swallow whole, do not crush or chew.
-
Can be taken with or without food.
-
Follow the dosing schedule as prescribed by your oncologist.
Precautions:
-
Not recommended during pregnancy; causes severe birth defects.
-
Use effective contraception (both males and females) during and for several weeks after treatment.
-
Regular blood tests are essential to monitor blood counts.
-
Avoid if you have a history of blood clots unless prescribed with precautions.
-
Inform your doctor if you have liver, kidney, or heart problems.
Drug Interactions:
Lenmid may interact with:
-
Dexamethasone (increases risk of blood clots)
-
Erythropoietin-stimulating agents
-
Anticoagulants (warfarin, enoxaparin)
-
Immunosuppressants
-
Other chemotherapy drugs
-
Hormonal therapies
Always inform your doctor of all medications and supplements you're taking.
Aller gies:
-
Do not use if allergic to Lenalidomide or any of its excipients.
-
Symptoms of allergic reactions may include rash, itching, swelling, dizziness, or difficulty breathing.
Overdose Information:
-
In case of an overdose, seek emergency medical help immediately.
-
Symptoms may include severe dizziness, fainting, or extreme fatigue.
-
There is no specific antidote; treatment is supportive and symptom-based.
Missed Dose Instructions:
-
If you miss a dose and it’s less than 12 hours late, take it as soon as remembered.
-
If more than 12 hours late, skip the missed dose and resume your regular schedule.
-
Do not double the dose to make up for a missed one.
Additional Notes:
-
This medication is part of a Risk Evaluation and Mitigation Strategy (REMS) program in some countries due to its teratogenic effects.
-
Handle capsules with care; avoid opening or crushing them.
-
Periodic monitoring for blood counts and organ function is necessary.
-
Patients should carry identification stating they are on Lenalidomide therapy.
-
Avoid activities requiring alertness (e.g., driving) until you know how the drug affects you.
